Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares OutstandingShares Outstanding
Ratios

Pliant Therapeutics (PLRX) Shares Issued (2019 - 2023)

Pliant Therapeutics has reported Shares Issued over the past 5 years, most recently at $270.3 million for Q1 2023.

  • Quarterly Shares Issued changed N/A to $270.3 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $270.3 million through Dec 2023, up 25.0% year-over-year, with the annual reading at $270.3 million for FY2023, 25.0% up from the prior year.
  • Shares Issued was $270.3 million for Q1 2023 at Pliant Therapeutics, up from $216.2 million in the prior quarter.
  • Over five years, Shares Issued peaked at $270.3 million in Q1 2023 and troughed at -$143.1 million in Q3 2020.
  • The 5-year median for Shares Issued is $198500.0 (2020), against an average of $28.6 million.
  • Year-over-year, Shares Issued tumbled 1022378.57% in 2020 and then soared 30697.86% in 2022.
  • A 5-year view of Shares Issued shows it stood at -$146000.0 in 2019, then plummeted by 6446.58% to -$9.6 million in 2020, then skyrocketed by 74.44% to -$2.4 million in 2021, then soared by 8949.82% to $216.2 million in 2022, then grew by 25.0% to $270.3 million in 2023.
  • Per Business Quant, the three most recent readings for PLRX's Shares Issued are $270.3 million (Q1 2023), $216.2 million (Q3 2022), and -$2.4 million (Q4 2021).